Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy

Immune checkpoint inhibitors (ICI) have the potential to worsen pre-existing anti-Hu paraneoplastic neurologic syndrome (PNS).

Currently, there are few data on Antiphospholipid antibodies (aPL Ab) in COVID-19 and it is unclear if they represent an epiphenomenon or are involved in pathogenesis of COVID-19 disease.

Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome

Thyroid dysfunctions and autoimmunity in breast cancer patients: a prospective case-control study

Systemic sclerosis is a rare acquired systemic disease characterised by a complex pathogenesis and multi organ involvement

Pro‑inflammatory properties of H‑ferritin on human macrophages, ex vivo and in vitro observations

SARS-CoV-2-related atypical thyroiditis

Coronavirus disease 2019 (COVID-19) has been categorized as evolving in overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the majority, perhaps 80% of patients.

Worldwide, many national vaccination programs have included the bacillus Calmette-Guérin (BCG) vaccine during infancy as a protection from infection [1]